Seems like this is a similar starting point to what happened in Germany. All were wishful that it was just a way of leveraging a better position for Germany.
That belief was dashed when Amarin eventually pulled out of the German market.
Without being negative I predict that Spain is on the same path.
Amarin's golden egg appears to have been only gold plated and we can only guess what the substrate is.
It's hard to believe that a drug with so many positive results has become a drug in which there is no apparent interest.
Market Data 
Markets 
AI
